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Abstract
Background: Early molecular changes of nutritionally-induced insulin resistance are still enigmatic.
It is also unclear if acute overnutrition alone can alter insulin signaling in humans or if the
macronutrient composition of the diet can modulate such effects.
Methods:  To investigate the molecular correlates of metabolic adaptation to either high-
carbohydrate (HC) or high-fat (HF) overfeeding, we conducted overfeeding studies in 21 healthy
lean (BMI < 25) individuals (10 women, 11 men), age 20-45, with normal glucose metabolism and
no family history of diabetes. Subjects were studied first following a 5-day eucaloric (EC) diet (30%
fat, 50% CHO, 20% protein) and then in a counter balanced manner after 5 days of 40% overfeeding
of both a HC (20% fat, 60% CHO) diet and a HF (50% fat, 30% CHO) diet. At the end of each diet
phase,  in vivo insulin sensitivity was assessed using the hyperinsulinemic-euglycemic clamp
technique. Ex vivo insulin action was measured from skeletal muscle tissue samples obtained 15
minutes after insulin infusion was initiated.
Results: Overall there was no change in whole-body insulin sensitivity as measured by glucose
disposal rate (GDR, EC: 12.1 ± 4.7; HC: 10.9 ± 2.7; HF: 10.8 ± 3.4). Assessment of skeletal muscle
insulin signaling demonstrated increased tyrosine phosphorylation of IRS-1 (p < 0.001) and
increased IRS-1-associated phosphatidylinositol 3 (PI 3)-kinase activity (p < 0.001) following HC
overfeeding. In contrast, HF overfeeding increased skeletal muscle serine phosophorylation of IRS-
1 (p < 0.001) and increased total expression of p85α (P < 0.001).
Conclusion: We conclude that acute bouts of overnutrition lead to changes at the cellular level
before whole-body insulin sensitivity is altered. On a signaling level, HC overfeeding resulted in
changes compatible with increased insulin sensitivity. In contrast, molecular changes in HF
overfeeding were compatible with a reduced insulin sensitivity.
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Background
Overnutrition associated with weight gain can lead to
obesity and insulin resistance [1-6]. Eventually individu-
als can develop type 2 diabetes mellitus (T2DM) and car-
diovascular disease leading to a significant increase in
morbidity and mortality. We aimed to unravel the earliest
molecular changes associated with the development of
insulin resistance as a result of overnutrition and to deter-
mine if acute bouts of caloric excess, before weight gain
occurs, can lead to changes in insulin signaling.
There is a paucity of literature studying short-term over-
feeding of normal lean individuals. Animal studies have
shown that overfeeding can induce insulin resistance
acutely [7]. Human studies have shown that varying
amounts and duration of overfeeding can lead to eleva-
tions in fasting insulin levels in the setting of normoglyc-
emia [8-14]. Our group has previously found that 3 days
of overfeeding (50% caloric excess) in lean healthy indi-
viduals led to a significant decrease in whole-body insulin
sensitivity [15,16]. Most recently, Brøns, et al. found that
5 days of high-fat overfeeding (50% caloric excess) in lean
individuals resulted in no change in whole-body insulin
sensitivity as measured by M-value and Glucose Disposal
Rate (GDR) [17]. Therefore, it remains unclear if acute
overnutrition alone can induce insulin resistance in
humans. If acute overfeeding can impact insulin sensitiv-
ity, the next question is whether the effect is altered by the
macronutrient content of the consumed diet. Although
many studies in the literature have assessed macronutrient
effects on insulin sensitivity [18-22] these studies were not
performed in the setting of overfeeding. Population stud-
ies have shown that diets rich in fat appear to be associ-
ated with development of insulin resistance, obesity and
T2DM [23,24]. There have also been reports that diets rich
in carbohydrates with a high glycemic index may be asso-
ciated with increased hepatic glucose production and the
development of T2DM [25,26].
The potential link between energy intake and changes in
insulin action remain unclear. At a whole body level, insu-
lin resistance can be defined when higher than normal
concentrations of insulin are necessary to maintain eugly-
cemia. On a cellular level, metabolic insulin resistance is
known to display a reduced strength of signaling via the
insulin receptor substrate (IRS)-phophatidylinositol (PI)
3-kinase pathway. In almost all cases of insulin resistance
there is a decline in PI 3-kinase activity [27-29]. Two com-
plementary mechanisms have emerged as potential expla-
nations for the reduced strength of the IRS-PI 3-kinase
signaling pathway. First, PI 3-kinase activity is minimized
secondary to serine phosphorylation of IRS proteins by
intracellular signaling intermediates such as mTOR-p70
S6 (S6K1) kinase-dependent mechanism or other kinases
(JNK, IKKβ, or PKC). Serine phosphorylation of IRS pro-
teins results in a diminished ability of IRS proteins to
attract PI 3-kinase [30-37]. In response to insulin and
amino acids mammalian target of rapamycin (mTOR), a
serine/threonine kinase, phosphorylates and modulates
activity of S6K1 kinase [38-40]. The insulin activation of
mTOR and S6K1 kinase works through the IRS-1/PI 3-
kinase/Akt pathway, while amino acids seem to exert a
direct effect on mTOR [41,42]. Activation of mTOR and
S6K1 kinase leads to serine phosphorylation of IRS-1,
with a subsequent decline in tyrosine phosphorylation of
IRS-1 and IRS-1-associated PI 3-kinase activity, as dis-
cussed above. Although many mechanisms leading to ser-
ine phosphorylation of IRS proteins have been explored,
the nutritional effect on this process in humans is not
completely understood.
Second, a disruption in the balance between the amounts
of the PI 3-kinase subunits may play a role in the develop-
ment of insulin resistance [43,44]. This enzyme consists
of a regulatory subunit, p85, and a catalytic subunit, p110
[45]. Normally, p85 monomer exists in excess to p110.
Since the p85 subunit of PI 3-kinase directly binds to IRS-
1, there exists a competition between the free p85 mono-
mer and the p85-p110 heterodimer for the binding site on
IRS-1. Since only the heterodimer is responsible for PI 3-
kinase activity, increases or decreases in p85 expression
could lead to increased or decreased PI 3-kinase activity in
an inverse manner [46-49]. We have previously demon-
strated that in the women who displayed reduced whole-
body insulin sensitivity following 3 days of 50% overfeed-
ing there was an increase in total p85α (the most abun-
dant isoform of p85) expression in skeletal muscle. This
increase in p85α expression was inversely correlated with
PI 3-kinase activity [16].
We thus hypothesized that acute bouts of overnutrition
would alter skeletal muscle insulin signaling prior to see-
ing changes in whole body insulin sensitivity. Moreover,
we hypothesized that high fat overnutrition would result
in greater impairment in insulin signaling than high car-
bohydrate overnutrition. The present study was designed
to examine these hypotheses.
Methods
Subjects
Twenty-one lean (BMI 21.8 ± 1.8), healthy men (n = 11)
and women (n = 10) with normal glucose tolerance (as
determined by oral glucose tolerance testing) completed
the study (Table 1). The study was approved by the Colo-
rado Multiple Institutional Review Board, and all subjects
gave informed consent.
Materials
Bovine serum albumin (BSA) and protease inhibitors
aprotinin and leupeptin were purchased from BoehringerNutrition & Metabolism 2009, 6:37 http://www.nutritionandmetabolism.com/content/6/1/37
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Mannheim (Indianapolis, IN, USA). Antibodies to IRS-1,
and p85α were purchased from Upstate Biotechnology
(Lake Placid, NY, USA). Antibodies to p110 were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Anti-phosphoserine IRS-1 antibody was from
Upstate Biotechnology, pY-20 antibody was from BD
Transduction Laboratories (San Diego, CA, USA). Anti-
bodies to mTOR, phospho-mTOR, p70S6 kinase (S6K1)
and phospho-p70S6 kinase (Thr 3389 and Thr421/
Ser424) were from Cell Signaling Technology (Danvers,
MA, USA). Secondary horseradish-peroxidase-conjugated
antibody, protein A Sepharose and chemeluminescence
detection reagent, ECLplus Western Blotting Analysis Sys-
tem, and ImageQuant TL software from GE Healthcare
Bio Science/Amersham Biosciences, Piscataway, NJ. γ32P-
ATP was purchased from Perkins-Elmer (Boston, MA).
Whatman flexible plates for thin layer chromatography
were obtained from Fisher Scientific (Denver, CO). Ana-
lytical grade resins, polyvinylidene difluoride mem-
branes, PAGE gel equipment and protein assay kits were
from Bio-Rad Laboratories (Hercules, CA, USA).
Study Design
Subjects first underwent baseline assessments of resting
metabolic rate (RMR) using the SensorMedics Vmax Spec-
tra 29 metabolic cart (Sensormedics, Yorba Linda, CA)
and body composition determined by dual x-ray absorp-
tiometry (DEXA) using Hologic Discovery version 12.6.
Subjects were then studied on three separate occasions
with a one month wash-out between study visits. The first
study day served as a baseline and was performed after
subjects were fed a eucaloric diet (30% fat, 50% carbohy-
drate, 20% protein) for 5 days. Estimates of daily energy
needs were made using several factors: 1) the Harris-Ben-
edict equation, 2) baseline RMR plus an activity factor,
and 3) lean body mass. Subjects were then studied after 5
days of high-carbohydrate (HC; 20% fat, 60% carbohy-
drate, 20% protein) and 5 days of high-fat (HF; 50% fat,
30% carbohydrate, 20% protein) overfeeding (40%
caloric excess over a eucaloric diet) in a cross-over coun-
ter-balanced manner. Because the two hypercaloric diets
contained 40% excess calories, carbohydrate intake on the
HF diet and fat intake on the HC diet were similar to
amounts consumed during eucaloric feeding (example:
eucaloric 2000 kCal diet contained 66.7 g fat, 250 g CHO
and 100 g protein; HC 2800 kCal diet contained 62.2 g
fat, 420 g CHO and 140 g protein; HF 2800 kCal diet con-
tained 155.6 g fat, 210 g CHO and 140 g protein). Dietary
lipid for all diets contained a 1:1:1 ratio of monounsatu-
rated, polyunsaturated and saturated fats. Food for all
study diets (eucaloric, HC and HF) was provided by the
Clinical and Translational Research Center (CTRC)
kitchen. Subjects selected food choices from the CTRC
kitchen menu (Additional File 1). The HC diet was
enriched in fruits and starches. The HF diet was enriched
in dairy, nuts, and oils. Subjects presented to the CTRC
every morning to pick up food and be weighed. Subjects
were asked to maintain their usual level of activity
throughout the study. They were also asked not to con-
sume any alcoholic or calorie-containing beverages.
Study Days
Subjects were admitted to the inpatient CTRC the night of
day 5 for each of the three diet phases for an overnight
fast. The next morning a euglycemic-hyperinsulinemic
clamp and skeletal muscle biopsy were performed. An
antecubital venous catheter was placed in one arm for
infusions, and another catheter was placed retrograde in a
dorsal hand vein of the contralateral arm for sampling,
using the heated hand technique to obtain arterialized
venous blood. Glucose production and disposal were
measured using a euglycemic-hyperinsulinemic clamp.
After baseline blood samples were taken a primed (19
μmol/kg), constant (0.22 μmol/kg/min) infusion of [6,6-
2H2] glucose was started to measure glucose disposal rate.
A primed, continuous infusion of insulin at 40 mU/m2/
min was then initiated and continued from time 120 to
240 minutes. Blood samples were taken at 90, 100, 110,
220, 230, and 240 min for steady state measurements of
metabolites and isotope enrichments. Blood samples
were taken every 5 minutes during the insulin infusion for
bedside glucose analysis, and a 20% dextrose solution
enriched with [6,6-2H2] glucose was infused and adjusted
to maintain euglycemia at a blood glucose level of approx-
imately 90 mg/dl. Rates of glucose appearance (Ra) and
disappearance (Rd) were calculated using the modified
Steele equation [50,51]. The skeletal muscle biopsy was
performed once the insulin prime was complete (after 15
minutes) in order to assess insulin-stimulated effects on
PI 3-kinase activity. Subcutaneous tissue overlying the vas-
tus lateralis muscle was infiltrated with 1% lidocaine. A
small incision was made with a scalpel down through the
level of the fascia. A Bergstrom sidecut biopsy needle with
suction was used to remove approximately 0.25 g of skel-
etal muscle tissue. Tissue samples were frozen immedi-
ately using the "freeze clamp" method. The biopsy
samples were stored at -80°C until used.
Table 1: Baseline characteristics
Characteristic Value
N (M/W) 21 (11/10)
Age (years) 27.8 ± 0.9
Weight (kg) 66.6 ± 1.5
BMI (kg/m2) 21.8 ± 0.4
Waist Circumference (cm) 78.7 ± 1.7
Fat Free Mass (kg) 51.0 ± 2.1
Percent Body Fat (%) 21.9 ± 1.9
Mean ± SDNutrition & Metabolism 2009, 6:37 http://www.nutritionandmetabolism.com/content/6/1/37
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Determination of intramyocellular lipid content (IMCL)
In a subset of subjects (N = 10), intramuscular triglyceride
content of the soleus muscle was measured via 1H (pro-
ton) magnetic resonance spectroscopy (MRS) performed
using the 3.0 T whole-body MRI scanner (GE Medical Sys-
tems, Waukesha, WI). The spectroscopic acquisition is
performed using the probe-p (PRESS) pulse sequence
with parameters (TR/TE = 2000/100 ms, 128 averages,
total acquisition time 7 minutes) optimized to avoid sig-
nals from fat. The resulting spectra are analyzed using
LCModel software which fits the spectra using basis sets
consisting of solution metabolite spectra.
Clinical Laboratory Measurements
Plasma glucose level was measured throughout the eugly-
cemic-hyperinsulinemic clamp studies at the bedside
every 5 minutes using a YSI glucose analyzer (YSI Inc, Yel-
low Springs, OH). Baseline and steady-state analysis
included blood sampling for insulin, glucose, free fatty
acids (FFAs), glycerol, triglycerides, leptin, adiponectin,
TNF-α and interleukin (IL)-6. Insulin was determined by
radioimmunoassay (Diagnostic Systems Laboratory,
Webster, TX). Serum glucose levels were determined using
hexokinase, UV and triglycerides were determined by
enzymatic assay (Olympus America, Inc., Center Valley,
PA). FFAs were determined using an enzymatic assay
(WaKo Chemicals, Richmond, VA). Glycerol was deter-
mined using an enzymatic assay (R-Biopharmm Inc., Mar-
shall, MI). Leptin and adiponectin levels were determined
by radioimmunoassays (Linco Research, Inc., St. Charles,
MO). TNF-α and IL-6 were determined by ELISA (R&D
Systems, Minneapolis, MN). Glucose isotopic enrichment
was measured by gas chromatography/mass spectrometry
(Metabolic Solutions, Inc., Nashua, NH).
Western Blot Analysis
Immunoprecipitated IRS-1 was immunoblotted with
pY20 and anti-serine 307 IRS-1 antibodies to determine
extent of tyrosine and serine phosphorylation of IRS-1 as
well as with anti-IRS-1 antibody for assessment of total
IRS-1. Immunoprecipitated IRS-1 was also immunoblot-
ted with p110 antibodies to determine the total amount
of IRS-1-associated p110 expression. Tissue homogenates
were immunoprecipitated and immunoblotted with
p85α specific antibody for assessment of p85α protein
expression. Finally, homogenates were also immunopre-
cipitated with mTOR and S6K1 specific antibodies and
then blotted with phospho-mTOR (serine 2448) and
phospho-S6K1 kinase (serine 371) antibodies, respec-
tively. The total amounts of mTOR and S6k1 kinase were
determined by immunoblotting with corresponding spe-
cific antibodies.
Determination of IRS-1-associated PI 3-kinase activity
Lysates prepared from the tissue biopsy were immunopre-
cipitated with IRS-1 antibody. PI 3-kinase activity is deter-
mined in 1 to 3 μL of the immunoprecipitate by the thin
layer chromatography as described in several of our pub-
lications [52].
Statistical Analysis
Data are presented as mean ± SEM. Statistical analysis
were done using SigmaStat software (Jandel Scientific, San
Rafael, CA, USA). The effects of study diets were analyzed
using repeated measures analysis of variance (ANOVA). p-
values of < 0.05 were considered statistically significant.
No gender differences were found, so all results reported
include data from men and women combined as one
cohort.
Results
In Vivo
After 5 days of eucaloric (EC) feeding, baseline whole-
body insulin sensitivity and hepatic glucose production
were determined by euglycemic-hyperinsulinemic clamp.
Subjects were then studied after 5 days of high-carbohy-
drate (HC) and high-fat (HF) overfeeding in a counter
balanced manner. There was no difference in weight
between study days (EC: 66.6 ± 1.6 kg; HC: 67.5 ± 1.5 kg,
HF: 67.2 ± 1.6 kg, p = 0.92). HC overfeeding resulted in
increased fasting insulin and triglyceride concentrations
and lower fasting free fatty acid concentrations as com-
pared to EC feeding (Table 2). HF overfeeding was associ-
ated with a significant decrease in triglyceride
concentrations compared to EC and HC feedings
(Table 2).
Interestingly, five days of HC or HF overfeeding did not
alter whole-body insulin sensitivity compared to eucaloric
feeding, expressed as either M-Value or GDR (Table 3).
Steady-state serum glucose and insulin levels were equiv-
alent at the end of the euglycemic-hyperinsulinemic
clamp for all three study days (Table 3). There was also no
significant change in basal hepatic glucose output follow-
ing either overfeeding diet (Table 3).
Table 2: Fasting metabolic data
EC HC HF
Insulin (mU/mL) 4.2 ± 0.4 5.8 ± 0.6* 4.4 ± 0.4
Glucose (mg/dL) 84.2 ± 1.3 85.5 ± 1.7 84.9 ± 1.4
FFA (μEq/L) 447 ± 41 315 ± 32.5* 404 ± 25.3
Triglycerides (mg/dL) 69.1 ± 5.9 91.0 ± 11.0** 60.6 ± 7.9#
Glycerol (μM/L) 72.1 ± 7.8 73.2 ± 11.4 69.6 ± 8.9
Adiponectin (μg/mL) 10.0 ± 1.2 9.9 ± 1.1 9.5 ± 1.2
Leptin (ng/mL) 6.2 ± 1.6 8.3 ± 2.1 6.5 ± 1.5
TNF-α (pg/mL) 2.1 ± 0.4 2.2 ± 0.5 2.0 ± 0.4
Interleukin-6 (pg/mL) 0.9 ± 0.1 0.9 ± 0.1 1.3 ± 0.5
Mean ± SE.
EC = eucaloric diet, HC = high-carbohydrate overfeeding, HF = high-
fat overfeeding
*p < 0.03 compared to EC, **p < 0.001 compared to EC, #p < 0.001 
compared to HCNutrition & Metabolism 2009, 6:37 http://www.nutritionandmetabolism.com/content/6/1/37
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Measurements of serum adipokines and markers of sys-
temic inflammation revealed no significant change in
serum adiponectin or leptin levels following overfeeding
with either HC or HF diets. Similarly, there was no signif-
icant change in TNFα or interleukin-6 levels following
either overfeeding diet (Table 2).
Finally, assessment of intramyocellular triglyceride con-
tent (IMCL) performed in a subset of subjects (N = 10) fol-
lowing both HC and HF overfeeding demonstrated 17-
22% increases in IMCL accumulation after both diets (EC:
1077.0 ± 103.2, HC: 1323.3 ± 137.6 p  = 0.0025, HF:
1268.8 ± 128.9 p = 0.0136).
Ex Vivo
We then examined ex vivo markers of insulin signaling in
skeletal muscle of individuals enrolled into this study. All
biopsies were obtained at the end of each feeding period
in the insulin-stimulated condition. Five days of HC over-
feeding resulted in significant increases in tyrosine phos-
phorylation of IRS-1 (Figure 1A), with no change in total
IRS-1 protein expression compared to EC feeding (Figure
2). In contrast, HF overfeeding resulted in increased serine
phosphorylation of IRS-1 (Figure 1B) with no change in
the amount of total IRS-1 (Figure 2). Representative blots
of total and phosphorylated IRS-1 are shown in Figure 2
along with all subsequent blots discussed below.
In concert with these changes in IRS-1 phosphorylation,
insulin-stimulated IRS-1-associated PI 3-kinase activity
increased following HC overfeeding (Figure 3A). PI 3-
kinase is a heterodimer comprised of regulatory, p85, and
catalytic, p110, subunits. While p85 is responsible for
association of PI 3-kinase with IRS-1, it is actually associ-
ation of p110 with IRS-1 that determines PI 3-kinase activ-
ity. Therefore, we examined association of p110 with IRS-
1 in response to insulin in patients after 5 days of over-
feeding either HC or HF compared to 5 days of eucaloric
feeding. The IRS-1 associated p110 was significantly
increased following HC overfeeding (Figure 3B), support-
ing a positive influence of the HC diet on PI 3-kinase
activity.
Decreased association of PI 3-kinase with IRS-1 can be a
consequence of either serine phosphorylation of IRS-1 or
of an increased expression of p85 monomer that com-
petes with p85-p110 heterodimer for the IRS-1 binding
sites. Therefore, we examined total amounts of p85α (a
predominant isomer of p85) after overfeeding HC and
HF. Total p85α protein expression was increased follow-
ing HF overfeeding compared to eucaloric feeding leading
to enhanced competition with PI 3-kinase heterodimer,
thus contributing to the reduction in IRS-1 associated
p110 levels (Figure 3C). In contrast, p85α levels were
lower following HC overfeeding compared to HF over-
Table 3: Euglycemic-hyperinsulinemic clamp data
EC HC HF
M-Value (mg/kg FFM-min) 11.4 ± 2.7 11.2 ± 2.9 11.1 ± 2.1
GDR (mg/kg FFM-min) 12.1 ± 4.7 10.9 ± 2.7 10.8 ± 3.4
Steady State Glucose (mg/dL) 79.2 ± 5.1 81.8 ± 8.7 79.6 ± 8.8
Steady State Insulin (mU/mL) 66.8 ± 22.3 60.2 ± 17.4 59 ± 27.1
MCR (mL/m2-min) 719 ± 263.5 785 ± 175.2 825 ± 232.6
Rest HGO (mg/kg FFM-min) 3.39 ± 0.5 3.79 ± 1.5 3.42 ± 1.0
Mean ± SE.
EC = eucaloric diet, HC = high-carbohydrate overfeeding, HF = high-fat overfeeding
GDR = glucose disposal rate, MCR = metabolic clearance rate of insulin, HGO = hepatic glucose output
Phosphorylation of IRS-1 Figure 1
Phosphorylation of IRS-1. Tyrosine (A) and Serine (B) 
phosphorylation of IRS-1 in skeletal muscle following Euca-
loric feeding (EC), high-carbohydrate overfeeding (HC), and 
high-fat overfeeding (HF). HC overfeeding increased tyrosine 
phosphorylation of IRS-1 compared to EC feeding. HF over-
feeding increased serine phosphorylation of IRS-1 compared 
to EC feeding.
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feeding, thus maintaining minimal competition with PI
3-kinase for the IRS-1 binding sites (Figure 3C).
Looking further downstream from PI 3-kinase, we
assessed changes in the nutrient sensor, mTOR, and its
effect on S6K1 kinase. Total protein expression of mTOR
and S6K1 kinase was unchanged following the study diets
(Figure 2). However, there was a significant increase in
phosphorylated mTOR resulting in increased phosphor-
ylation of S6K1 following both overfeeding diets
(Figure 4).
Discussion
The salient feature of the current study is that short-term
overfeeding in healthy lean individuals (40% caloric
excess for 5 days) results in significant changes in skeletal
muscle insulin signaling before any alterations in total
body insulin sensitivity are evident. Furthermore, macro-
nutrient composition of the overfeeding diet has a pro-
found influence on changes in insulin signaling in skeletal
muscle.
We found that consuming a high-carbohydrate (HC)
hypercaloric diet results in a significant increase in tyro-
sine phosphorylation IRS-1, with increased association of
p110 (a catalytic subunit of PI 3-kinase) with IRS-1 and
Representative blots Figure 2
Representative blots. Representative blots from ex vivo 
skeletal muscle tissue following Eucaloric feeding (EC), high-
carbohydrate overfeeding (HC), and high-fat overfeeding 
(HF).
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enhanced IRS-1-associated insulin-stimulated PI 3-kinase
activity. These changes in insulin signaling usually denote
increased insulin sensitivity and may be a result of the
modest hyperinsulinemia seen with HC overfeeding.
Whole body insulin sensitivity as measured by the eugly-
cemic-hyperinsulinemic clamp, however, did not change
after 5 days of overfeeding, suggesting the presence of
early changes in insulin signaling in response to a high-
carbohydrate load directed at better disposal of this load
in order to maintain whole-body insulin sensitivity.
In contrast, we found that high-fat (HF) overfeeding
results in a significant increase in serine phosphorylated
IRS-1, a traditional determinant of insulin resistance. At
the same time, HF overfeeding is associated with
increased expression of p85α and decreased association of
p110 with IRS-1 and decreased insulin-stimulated PI 3-
kinase activity. Although in the present study we cannot
determine which component (serine phosphorylation of
IRS-1 or increased expression of p85α) plays a greater role,
these changes are typically associated with insulin resist-
ance in skeletal muscle. In our previous studies, overfeed-
ing healthy female subjects with 50% caloric excess for 3
days, we also observed an increase in expression of p85α
before serine phosphorylation of IRS-1 [16], suggesting
that excess energy intake may drive overexpression of
p85α as an earliest molecular change in response to over-
feeding. As with HC overfeeding, these ex-vivo alterations
were not accompanied by any change in the in vivo assess-
ment of insulin sensitivity. Excess fat intake appears to
alter carbohydrate induced insulin signaling at the level of
skeletal muscle but without an appreciable change in
whole body insulin sensitivity. These findings again imply
the appearance of early changes to acute bouts of overnu-
trition; however, the effects vary depending on the macro-
nutrient composition of the diet.
Assessing effects further downstream of PI 3-kinase, we
found that both HC and HF overfeeding led to significant
increases in activation of the nutrient sensor, mTOR, and
its downstream target, S6K1. Ability of S6K1 to promote
serine phosphorylation of IRS-1 has been suggested as a
potential mechanism of insulin resistance [30-37,53,54].
In this study, both overfeeding diets induced significant
increases in phosphorylation of mTOR and S6K1, yet only
HF overfeeding was associated with increased serine phos-
phorylation of IRS-1. Further studies are needed to evalu-
ate this discrepancy.
Interestingly, in a subset of subjects, we found a signifi-
cant increase in intramyocellular lipid content (IMCL) fol-
lowing both HC and HF overfeeding compared to
baseline. This increase was observed regardless of the
macronutrient content of the diet. This increase in IMCL
was also seen in the setting of unchanged whole-body
insulin sensitivity, suggesting that either IMCL is not asso-
ciated with insulin sensitivity, the duration of the study
was not sufficient to see an effect, or the type or source of
myocellular lipid may be important. Although literature
suggests that increases in intramuscular triglyceride are
associated with increased insulin resistance [55-57], some
data suggest these may not be related [58,59]. Addition-
ally, studies have shown that the source of intramyocellu-
lar lipid may determine how the lipid accumulation
affects insulin responsiveness. Ceremide and diacylglyc-
erol (DAG) have been linked to deleterious effects on
insulin signaling in muscle and DAG levels can increase
following intake of a diet high in saturated fat [60,61]. In
contrast, triacylglycerol fatty acids (TAG) accumulate in
muscle following a diet high in poluyunsaturated fatty
acids and can lead to improved insulin sensitivity [61].
Clearly further studies are needed to understand the rela-
tionship and interaction between IMCL and insulin sign-
aling. Future studies would be strengthened by
performing direct measurements of intramyocellular lipid
metabolites.
There are a few limitations to this study that need to be
discussed. First, the duration and amount of overfeeding
were chosen to be 5 days and 40%, respectively. It is pos-
mTOR and S6K1 activity Figure 4
mTOR and S6K1 activity. Phosphorylation of mTOR (A) 
and S6K1 (B) in skeletal muscle following Eucaloric feeding 
(EC), high-carbohydrate overfeeding (HC), and high-fat over-
feeding (HF). Both HC and HF overfeeding increased phos-
phorylation of mTOR and S6K1 compared to EC feeding.
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sible that a longer duration of overnutrition is necessary to
impact whole-body insulin sensitivity. Brøns, et al.
recently published data where they also did not see any
appreciable difference in whole-body insulin sensitivity,
as measured by euglycemic-hyperinsulinemic clamp fol-
lowing 5 days of 50% caloric excess feeding [17]. Conceiv-
ably, changes in the whole-body insulin sensitivity may
not be seen either until an individual begins to show clin-
ically significant weight gain or there is a more significant
caloric excess. Studies examining longer term overfeeding
should be performed to further assess this issue. Second,
despite strict eligibility criteria there was significant heter-
ogeneity in baseline measures of insulin sensitivity (M-
value: 7.68 to 17.71 mg/kgFFM/min). While we did not
see an association between baseline insulin sensitivity and
responses to overfeeding there may be differences in how
individuals can or cannot respond to overnutrition based
on their baseline insulin sensitivity. Studies in larger
cohorts of subjects might be needed to uncover changes in
whole-body insulin sensitivity following overnutrition.
Conclusion
We conclude that acute bouts of overnutrition lead to
early changes at the cellular level before whole-body insu-
lin sensitivity is altered. Our lean healthy cohort of sub-
jects may be metabolically flexible and thus able to adapt
to such changes in their diet. High carbohydrate overfeed-
ing induced mild elevations in insulinemia and triglyceri-
demia, while still suppressing FFA, hepatic glucose
production and stimulating glucose disposal. On a signal-
ing level, HC overfeeding induced changes compatible
with increased insulin sensitivity. In contrast, molecular
changes in HF overfeeding were compatible with a
reduced insulin sensitivity, while in vivo insulin sensitiv-
ity remained unchanged. More studies are needed to
determine when these early responses can no longer sus-
tain normal whole-body insulin sensitivity and which
individuals may not be as capable of adapting to overnu-
trition and why.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
RLA conducted euglycemic-hyperinsulinemic clamps,
performed skeletal muscle biopsies, analyzed in vivo data,
performed the statistical analysis and drafted the manu-
script. JWL performed all ex vivo analysis of skeletal mus-
cle tissue. KG was the study coordinator, organized all
subject visits and assisted with euglycemic-hyperinsuline-
mic clamps. BD co-conceived of the study, and partici-
pated in its design and coordination, assisted with data
analysis and helped draft the manuscript. MAC co-con-
ceived of the study, and participated in its design and
coordination, conducted euglycemic-hyperinsulinemic
clamps, performed skeletal muscle biopsies, assisted with
data analysis and statistical analysis and helped draft the
manuscript. All authors read and approved the final man-
uscript.
Additional material
Acknowledgements
This work was supported by NIH/NCRR Colorado CTSI Grant Number 
UL1 RR025780, NIH/NIDDK Clinical Nutrition Research Unit Grant 
Number DK48520, NIH/NIDDK Grant Number R56 DK077041 (to M. 
Cornier), and The Department of Veterans Affairs Merit Review Award (to 
B. Draznin).
References
1. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G:
Insulin resistance and hypersecretion in obesity. European
Group for the Study of Insulin Resistance (EGIR).  J Clin Invest
1997, 100:1166-1173.
2. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC: Obesity,
fat distribution, and weight gain as risk factors for clinical
diabetes in men.  Diabetes Care 1994, 17:961-969.
3. Colditz GA, Willett WC, Rotnitzky A, Manson JE: Weight gain as a
risk factor for clinical diabetes mellitus in women.  Ann Intern
Med 1995, 122:481-486.
4. Koh-Banerjee P, Wang Y, Hu FB, Spiegelman D, Willett WC, Rimm
EB: Changes in body weight and body fat distribution as risk
factors for clinical diabetes in US men.  Am J Epidemiol 2004,
159:1150-1159.
5. Olefsky JM, Kolterman OG, Scarlett JA: Insulin action and resist-
ance in obesity and noninsulin-dependent type 2 diabetes
mellitus.  Am J Physiol 1982, 243:E15-E30.
6. Lazar MA: How obesity causes diabetes: not a tall tale.  Science
2005, 307:373-375.
7. Wang J, Obici S, Morgan K, Barzilai , Feng Z, Rossetti L: Overfeeding
rapidly induces leptin and insulin resistance.  Diabetes 2001,
50:2786-2791.
8. Horton TJ, Drougas H, Brachey A, Reed GW, Peters JC, Hill JO: Fat
and carbohydrate overfeeding in humans: different effects
on energy storage.  Am J Clin Nutr 1995, 62:19-29.
9. Chinayon S, Goldrick RB: Effects of overfeeding on carbohy-
drate tolerance, insulin secretion, esterification and lipolysis
in healthy subjects.  Horm Metab Res 1978, 10:182-186.
10. Clore JN, Helm ST, Blackard WG: Loss of hepatic autoregulation
after carbohydrate overfeeding in normal man.  J Clin Invest
1995, 96:1967-1972.
11. Kashiwagi A, Mott D, Bogardus C, Lillioja S, Reaven GM, Foley JE:
The effects of short-term overfeeding on adipocyte metabo-
lism in Pima Indians.  Metabolism 1985, 34:364-370.
12. Kolaczynski JW, Ohannesian JP, Considine RV, Marco CC, Caro JF:
Response of leptin to short-term and prolonged overfeeding
in humans.  J Clin Endocrinol Metab 1996, 81:4162-4165.
13. Oppert JM, Nadeau A, Tremblay A, Després JP, Thériault G, Dériaz
O, Bouchard C: Plasma glucose, insulin, and glucagon before
and after long-term overfeeding in identical twins.  Metabolism
1995, 44:96-105.
14. Ravussin E, Schutz Y, Acheson KJ, Dusmet M, Bourquin L, Jéquier E:
Short-term, mixed-diet overfeeding in man: no evidence for
"luxuskonsumption".  Am J Physiol 1998, 249:E470-E477.
Additional file 1
Examples of Diets. The data provided represent an example of the types 
and amounts of foods for each diet for one subject.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1743-
7075-6-37-S1.DOC]Nutrition & Metabolism 2009, 6:37 http://www.nutritionandmetabolism.com/content/6/1/37
Page 9 of 10
(page number not for citation purposes)
15. Cornier MA, Bergman BC, Bessesen DH: The effects of short-
term overfeeding on insulin action in lean and reduced-
obese individuals.  Metabolism 2006, 55:1207-1214.
16. Cornier MA, Bessesen DH, Gurevich I, Leitner JW, Draznin B: Nutri-
tional up-regulation of p85a expression is an early molecular
manifestation of insulin resistance.  Diabetologia 2006,
49:748-754.
17. Brøns C, Jensen CB, Storgaard H, Hiscock NJ, White A, Appel JS,
Jacobsen S, Nilsson E, Larsen CM, Astrup A, Quistorff B, Vaag A:
Impact of short-term high-fat feeding on glucose and insulin
metabolism in young healthy men.  J Physiol 2009,
587:2387-2397.
18. Clore JN, Helm ST, Blackard WG: Loss of hepatic autoregulation
after carbohydrate overfeeding in normal man.  J Clin Invest
1995, 96:1967-1972.
19. Fach D, Minehira K, Schwarz JM, Periasami R, Seongsu P, Tappy L:
Effect of fructose overfeeding and fish oil administration on
hepatic de novo lipogenesis and insulin sensitivity in healthy
men.  Diabetes 2005, 54:1907-1913.
20. Sadur CN, Yost TJ, Eckel RH: Fat feeding decreases insulin
responsiveness of adipose tissue lipoprotein lipase.  Metabo-
lism 1984, 33:1043-1047.
21. Boden G, Chen X, Rosner R, Barton M: Effects of a 48-h fat infu-
sion on insulin secretion and glucose utilization.  Diabetes
1995, 44:1239-1242.
22. Boden G: Role of fatty acids in the pathogenesis of insulin
resistance and NIDDM.  Diabetes 1997, 46:3-10.
23. Marshall JA, Hamman RF, Baxter J: High-fat, low-carbohydrate
diet and the etiology of non-insul independent diabetes mel-
litus: the San Luis Valley Diabetes Study.  Am J Epidemiol 1991,
134:590-603.
24. Pereira MA, Kartashov Al, Ebbeling CB, Van Horn L, Slattery ML,
Jacobs Jr  DR, Ludwig DS: Fast-food habits, weight gain, and
insulin resistance (the CARDIA study): 15-year prospective
analysis.  Lancet 2005, 365:36-42.
25. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett
WC:  Dietary fiber, glycemic load, and risk of non-insulin-
dependent diabetes mellitus in women.  JAMA 1997,
277:472-477.
26. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett
WC, Hu FB: Sugar-sweetened beverages, weight gain, and
incidence of type 2 diabetes in young and middle-aged
women.  JAMA 2004, 292:927-934.
27. Shulman GI: Cellular mechanisms of insulin resistance in
humans.  Am J Cardiol 1999, 84:3J-10J.
28. Kahn BB, Flier JS: Obesity and insulin resistance.  J Clin Invest
2000, 106:473-481.
29. Pessin JE, Saltiel AR: Signaling pathways in insulin action:
molecular targets of insulin resistance.  J Clin Invest 2000,
106:165-169.
30. Qiao L, Goldberg JL, Russell JC, Sun XJ: Identification of enhanced
serine kinase activity in insulin resistance.  J Biol Chem 1999,
274:10625-10632.
31. White MF: Insulin signaling in health and disease.  Science 2003,
302:1710-1711.
32. Birnbaum MJ: Turning down insulin signaling.  J Clin Invest 2001,
108:655-659.
33. Um SH, Frogerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fum-
agalli S, Allegrini PR, Kozma SC, Auwerx J, Thomas G: Absence of
S6K1 protects against age- and diet-induced obesity while
enhancing insulin sensitivity.  Nature 2004, 431:200-205.
34. Patti M-E, Kahn BB: Nutrient sensor links obesity with diabetes
risk.  Nat Meal 2004, 10:1049-1050.
35. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF:
Phosphorylation of Ser307 in insulin receptor substrate-1
blocks interactions with the insulin receptor and inhibits
insulin action.  J Biol Chem 2002, 277:1531-1537.
36. Qiao L, Zhande R, Jetton TL, Zhou G, Sun XJ: In vivo phosphoryla-
tion of insulin receptor substrate 1 at serine 789 by a novel
serine kinase in insulin-resistant rodents.  J Biol Chem 2002,
277:26530-26539.
37. LeRoith D, Zick Y: Recent advances in our understanding of
insulin action and insulin resistance.  Diabetes Care 2001,
24:588-597.
38. Burnett PE, Barrow RK, Cohen NA, Snyder SH, Sabatini DM: RAFF1
phosphorylation of the translational regulators p70S6 kinase
and 4E-BP1.  Proc Natl Acad Sci USA 1998, 95:1432-1437.
39. Hara K, Yonezawa K, Kozlowski MT, Sugimoto T, Andrabi K, Weng
OP, Kasuga M, Nishimoto I, Avruch J: Regulation of eIF4E BP1
phosphorylation by mTOR.  J Biol Chem 1997, 272:26457-26463.
40. Isotani S, Hara K, Tokunaga C, Inoue H, Avruch J, Yonezawa K:
Immunopurified mammalian target of rapamycin phosphor-
ylates and activates p70S6 kinase [alpha] in vitro.  J Biol Chem
1999, 274:34493-34498.
41. Hinault C, Mothe-Satney I, Gautier N, Lawrence JC Jr, Van
Obberghen E: Amino acids and leucine allow insulin activation
of the PKB/mTOR pathway in normal adipocytes treated
with wortmannin and in adipocytes from db/db mice.  FASEB
J 2004, 18:1894-1896.
42. Pham P-TT, Heydrick SJ, Fox HL, Kimball SR, Jefferson LS Jr, Lynch CJ:
Assessment of cell-signaling pathways in the regulation of
mammalian target of rapamycin (mTOR) by amino acids in
rat adipocytes.  J Cell Biochem 2000, 79:427-441.
43. Giorgino F, Pedrini MT, Matera L, Smith RJ: Specific Increase in
p85a Expression in Response to Dexamethasone is Associ-
ated with Inhibition of Insulin-like Growth Factor-l Stimu-
lated Phosphatidylinositol 3-kinase Activity in Cultured
Muscle Cells.  J Biol Chem 1997, 272:7455-7463.
44. Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC, Kahn CR:
Molecular balance between the regulatory and catalytic sub-
units of phosphoinositide 3-kinase regulates cell signaling
and survival.  Mol Cell Biol 2002, 22:965-977.
45. Shepherd PR, Withers DJ, Siddle K: Phosphoinositide 3-kinase:
The key switch mechanism in insulin signaling.  Biochem J 1998,
333:471-490.
46. Terauchi Y, Tsuji Y, Satoh S, Minoura H, Murakami K, Okuno A, Inu-
kai K, Asano T, Kaburagi Y, Ueki K, Nakajima H, Hanafusa T, Matsu-
zawa Y, Sekihara H, Yin Y, Barrett JC, Oda H, Ishikawa T, Akanuma
Y, Komuro I, Suzuki M, Yamamura K-I, Kodama T, Suzuki H, Koyasu
S, Aizawa S, Tobe K, Fukui Y, Yazaki Y, Kadowaki T: Increased insu-
lin sensitivity and hypoglycaemia in Mice lacking the p85α
subunit of phosphoinositide 3-kinase.  Nature Genetics 1999,
21:230-235.
47. Ueki K, Algenstaedt P, Mauvais-Jarvis F, Kahn CR: Positive and neg-
ative regulation of phosphoinositide 3-kinase-dependent sig-
naling pathways by three different gene products of the p85α
regulatory subunit.  Mol Cell Biol 2000, 20:8035-8046.
48. Mauvais-Jarvis F, Ueki K, Fruman DA, Hirshman MF, Sakamoto K,
Goodyear LJ, Iannacone M, Accili D, Cantley LC, Kahn CR: Reduced
expression of the murine p85α subunit of phosphoinositide
3-kinase improves insulin signaling and ameliorates diabetes.
J Clin Invest 2002, 109:141-149.
49. Ueki K, Fruman DA, Uballe CM, Fasshauer M, Klein J, Asano T, Can-
tley LC, Kahn CR: Positive and negative roles of p85α and p85β
regulatory subunits of phosphoinositide 3-kinase in insulin
signaling.  J Biol Chem 2003, 278:48453-48466.
50. Steele R: Influences of glucose loading and of injected insulin
on hepatic glucose output.  Ann N Y Acad Sci 1959, 82:420-30.
51. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous
glucose production during hyperinsulinemic-euglycemic glu-
cose clamps. Comparison of unlabeled and labeled exoge-
nous glucose infusates.  Diabetes 1987, 36:914-24.
52. Barbour LA, Shao J, Qiao L, Leitner W, Anderson M, Friedman JE,
Draznin B: Human placental growth hormone increases
expression of p85 regulatory unit of phosphatidylinositol 3-
kinase and triggers severe insulin resistance in skeletal mus-
cle.  Endocrinol 2004, 145:1144-1150.
53. Khamzina L, Veilleux A, Bergeron S, Marette A: Increased activa-
tion of the mammalian target of rapamycin pathway in liver
and skeletal muscle of obese rats: possible involvement in
obesity-linked insulin resistance.  Endocrinol 2005,
146:1473-1481.
54. Trembley F, Gagnon A, Veilleux A, Sorisky A, Marette A: Activation
of the mammalian target of rapamycin pathway acutely
inhibits insulin signaling to Akt and glucose transport in 3T3-
L1 and human adipocytes.  Endocrinol 2005, 146:1328-1337.
55. Phillips DI, Caddy S, Fielding KN, Frayn KN, Borthwick AC, Taylor R:
Intramuscular triglyceride and muscle insulin sensitivity: evi-
dence for a relationship in nondiabetic subjects.  Metabolism
1996, 45:947-950.
56. Sinha R, Dufour S, Petersen KF, LeBon V, Enoksson S, Ma YZ, Savoye
M, Rothman DL, Shulman GI, Caprio S: Assessment of skeletal
muscle triglyceride content by 1H nuclear magnetic reso-
nance spectroscopy in lean and obese adolescents: relation-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Nutrition & Metabolism 2009, 6:37 http://www.nutritionandmetabolism.com/content/6/1/37
Page 10 of 10
(page number not for citation purposes)
ships to insulin sensitivity, total body fat, and central
adiposity.  Diabetes 2002, 51:1022-1027.
57. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C,
Jenkins AB, Storlien LH: Skeletal muscle triglyceride levels are
inversely related to insulin action.  Diabetes 1997, 46:983-988.
58. Goodpaster BH, He J, Watkins S, Kelley DE: Skeletal muscle lipid
content and insulin resistance: evidence for a paradox in
endurance-trained athletes.  J Clin Endocrinol Metab 2001,
86:5755-576.
59. Nadeau KJ, Ehlers LB, Aguirre LE, Reusch JE, Draznin B: Discord-
ance between intramuscular triglyceride and insulin sensitiv-
ity in skeletal muscle of Zucker diabetic rats after treatment
with fenofibrate and rosiglitazone.  Diabetes Obes Metab 2007,
9(5):714-23.
60. Ochiai M, Matsuo T: Effects of Short-Term Dietary Change
from High-Carbohydrate Diet to High-Fat Diet on Storage,
Utilization, and Fatty Acid Composition of Rat Muscle Trig-
lyceride during Swimming Exercise.  J Clin Biochem Nutr 2009,
44(2):168-177.
61. Lee JS, Pinnamaneni SK, Eo SJ, Cho IH, Pyo JH, Kim CK, Sinclair AJ,
Febbraio MA, Watt MJ: Saturated, but not n-6 polyunsaturated,
fatty acids induce insulin resistance: role of intramuscular
accumulation of lipid metabolites.  J Appl Physiol 2006,
100(5):1467-74.